DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa. - sprookjes - yvandenbroek - TriplyDB

DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.

DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.

http://www.wikidata.org/entity/Q35382338

about

Nonhuman primate models for HIV/AIDS vaccine development Poxvirus vectors as HIV/AIDS vaccines in humans The evolution of poxvirus vaccines Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine Novel directions in HIV-1 vaccines revealed from clinical trials Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans Differential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injection.Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection.Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.Therapeutic and prophylactic DNA vaccines for HIV-1.Modified Vaccinia Virus Ankara Vector Induces Specific Cellular and Humoral Responses in the Female Reproductive Tract, the Main HIV Portal of Entry.A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression.Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial.DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease.Pathology-Based Research in Africa.

P2860

Q26861148-C473B770-5728-4133-A161-DB480C4916A1 Q26995078-538F1FC1-DD92-44A6-BCAB-92A41F249F83 Q26995905-8CD1BA3F-37A4-48A8-951C-5FC20DB772D0 Q28482252-136C1AD1-BB6F-40F7-B895-2141796E1347 Q33645528-C830725F-6D75-4459-AD74-886BE7AD059B Q34230483-DC0FD433-2A0A-4D58-B9C2-D819F8934A46 Q34359593-781AE266-4AFA-4BC0-B168-086570CDBC7C Q35055188-88044DFE-DD49-4610-9EEC-B6D9174DF722 Q35099609-CCB2B065-2E7C-44EE-B62A-E0AAA3F3B0E0 Q35488175-47FFDFDB-654A-445E-BF81-48862878E2D9 Q35914311-3C8388A7-9F21-4684-A988-255AD2E6638C Q36106653-EA1DDD94-140F-4F97-9C40-3F4A62B80577 Q36668517-090BF383-333B-498B-8C58-322A62529D4E Q38088037-067714A4-2494-40DD-97B4-70DBCE614ED0 Q38369341-56462C6C-5594-4DC2-AA58-51BB85A89307 Q40220988-CBA90885-54FB-4093-B479-EEAEBF0E3F4C Q40339467-003E16FD-3528-41C2-86DF-7AA41FCCF502 Q41726535-AC6BA874-DBEB-4D0A-8D9A-456BDC177C7E Q41926056-81931CA6-A748-4F5D-AA87-B1EA2498FD8F Q41995910-A161DB5C-2F74-409C-897E-FF05F1A2DBD1 Q44318621-324353B8-61B0-4A32-94B3-24BB8616A2B2 Q50140471-F96436BA-7410-4C5B-90FE-1737761C5DB1

P2860

DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.

http://www.wikidata.org/entity/Q35382338

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.

@ast

DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.

@en

type

label

DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.

@ast

DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.

@en

prefLabel

DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.

@ast

DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.

@en

P1433

Q35382338-AC6DFC29-C9D2-4A8F-B4D2-5662D3020D7C

P1476

Q35382338-FAF24DF3-3663-4110-8859-E09C928E7DB8

P2093

Q35382338-0419F421-32B0-40F2-91A3-163C3579E3C2

Q35382338-172635B0-98F3-49B2-A7BB-8ECE0AD6C194

Q35382338-723D1E01-FE98-4C50-85F2-384E9A1F39A3

Q35382338-8E3150B1-E860-4505-AFF0-5557658FFD5E

Q35382338-ADD7B537-43D0-4552-9CDB-CA69A677371D

Q35382338-B3DD0064-5134-49DA-B0C1-EE6A4B5CA5A5

Q35382338-BB90A004-0477-499D-8CE8-CCBCC3998ABA

Q35382338-CC4DDFA0-A03A-4630-96CA-453A866E6D6C

Q35382338-E483EE3A-562E-4BED-93EF-A1CDA8D9B047

Q35382338-F1BE17CF-D071-4704-8622-9F66F51892AA

P2860

Q35382338-0E05A10D-E37F-4F8D-AA68-C3DD055124C6

Q35382338-0E11F31E-22A9-44BA-BD01-ECFDD534F757

Q35382338-13AB45AF-5119-4C7E-AFF2-CAEA2376E93E

Q35382338-14AB199A-FB31-422A-862A-72E4FF05614D

Q35382338-2779B730-E5CC-4C60-92F8-0871490B0F33

Q35382338-2C4B76D4-E81D-44CE-AF21-E8C62FD587FB

Q35382338-371A15DB-FA53-484B-AAFC-289081C7C334

Q35382338-37DCAEAB-5A2A-430D-9EA8-4BDB123ACB3B

Q35382338-470B4769-C6D7-41B9-BE06-E74AAA0C190B

Q35382338-4C494871-3F4B-4EA1-A42E-6F8E745867CA

P304

Q35382338-75C49DF1-6F03-42A7-8B20-EB6022859669

P31

Q35382338-9CD44CEC-6F4E-4D57-B9A8-8E9644D34FCE

P356

Q35382338-9096B52B-FEF0-44F6-ABAB-9F74659B70AE

P407

Q35382338-BEB03E5C-1361-4765-844D-BA797CB229A8

P433

Q35382338-A8CB44ED-EA4B-4F4D-B175-2CEB27E25E43

P478

Q35382338-2E28CFCD-E3C4-4A08-B9AB-590DC004FF07

P50

Q35382338-00EB6701-54BC-475D-ACF8-24D0215C2FA5

Q35382338-81F0EBB2-8EDB-4A7C-ABF4-95FDC1621DD5

Q35382338-E92E9AF1-10DA-4BCF-9DCC-DE8E006A9C86

P577

Q35382338-54A3CC5B-1FFA-4F66-B36E-C5533D0CA111

P5875

Q35382338-96A8DA8F-94C2-4A31-B029-2C3AE42879D1

P698

Q35382338-3974486B-02E0-4066-80F2-44FE74A743B5

P932

Q35382338-69FD8BB0-D64B-4024-96E0-379C97246A55

P356

P1433

Journal of Virology

P1476

DNA/NYVAC vaccine regimen indu ...... responses in intestinal mucosa

@en

P2093

Gian Dorta

http://www.w3.org/2001/XMLSchema#string

Hugh C Welles

http://www.w3.org/2001/XMLSchema#string

Jim Tartaglia

http://www.w3.org/2001/XMLSchema#string

Mariano Esteban

http://www.w3.org/2001/XMLSchema#string

Matthieu Perreau

http://www.w3.org/2001/XMLSchema#string

Michel Maillard

http://www.w3.org/2001/XMLSchema#string

Olivia Hall

http://www.w3.org/2001/XMLSchema#string

Pierre-Alexandre Bart

http://www.w3.org/2001/XMLSchema#string

Ralf Wagner

http://www.w3.org/2001/XMLSchema#string

Ricardo Martin

http://www.w3.org/2001/XMLSchema#string

P2860

Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity

The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9

The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Central memory and effector memory T cell subsets: function, generation, and maintenance

Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.

P304

9854-9862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00788-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Alexandre Harari

Giuseppe Pantaleo

P577

2011-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51508015

http://www.w3.org/2001/XMLSchema#string

P698

21775454

http://www.w3.org/2001/XMLSchema#string

P932

3196391

http://www.w3.org/2001/XMLSchema#string